We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Central Garden & Pet Co
CENT
$2.76B
| $253K | ﹤0.01% |
8,833
-81
| -0.9% | -$2.18K |
|
952
Visteon
VC
$2.85B
| $253K | ﹤0.01% |
3,703
+785
| +27% | +$49.3K |
|
953
J&J Snack Foods
JJSF
$1.49B
| $252K | ﹤0.01% |
1,984
-85
| -4% | -$10.7K |
|
954
Southern Copper
SCCO
$138B
| $252K | ﹤0.01% |
6,864
| – | – |
|
955
KKR & Co
KKR
$89.1B
| $251K | ﹤0.01% |
8,142
+4,158
| +104% | +$112K |
|
956
EPAM Systems
EPAM
$5.58B
| $249K | ﹤0.01% |
995
-1,374
| -58% | -$302K |
|
957
NBT Bancorp
NBTB
$2.82B
| $249K | ﹤0.01% |
8,142
+244
| +3% | +$7.6K |
|
958
Intellia Therapeutics
NTLA
$1.51B
| $249K | ﹤0.01% |
11,946
+4,399
| +58% | +$74.7K |
|
959
Fastly Inc
FSLY
$3.24B
| $246K | ﹤0.01% |
+2,910
| New | +$115K |
|
960
Construction Partners
ROAD
$5.88B
| $246K | ﹤0.01% |
13,905
+11,360
| +446% | +$194K |
|
961
Willis Towers Watson
WTW
$29.8B
| $246K | ﹤0.01% |
1,256
+148
| +13% | +$28.3K |
|
962
Masco
MAS
$14.6B
| $244K | ﹤0.01% |
4,898
+350
| +8% | +$15.2K |
|
963
AerCap
AER
$23.4B
| $243K | ﹤0.01% |
7,901
-528
| -6% | -$15.1K |
|
964
CRISPR Therapeutics
CRSP
$4.69B
| $243K | ﹤0.01% |
3,320
+770
| +30% | +$45K |
|
965
Federated Hermes
FHI
$4.56B
| $242K | ﹤0.01% |
10,233
+8,822
| +625% | +$195K |
|
966
Yeti Holdings
YETI
$3.87B
| $242K | ﹤0.01% |
+5,672
| New | +$170K |
|
967
Trimble
TRMB
$13.6B
| $239K | ﹤0.01% |
5,544
+2,317
| +72% | +$86.9K |
|
968
Vanguard Communication Services ETF
VOX
$5.68B
| $239K | ﹤0.01% |
2,573
+2,025
| +370% | +$179K |
|
969
AptarGroup
ATR
$8.69B
| $238K | ﹤0.01% |
2,129
-714
| -25% | -$76K |
|
|
LSXMK
970
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $237K | ﹤0.01% |
8,908
-569
| -6% | -$14.6K |
|
971
Vodafone
VOD
$37.1B
| $231K | ﹤0.01% |
14,571
-22,621
| -61% | -$341K |
|
972
Apollo Global Management
APO
$69B
| $230K | ﹤0.01% |
4,615
+2,915
| +171% | +$128K |
|
|
DRNA
973
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $230K | ﹤0.01% |
9,085
+2,230
| +33% | +$48K |
|
974
Invesco Water Resources ETF
PHO
$2.03B
| $229K | ﹤0.01% |
6,309
| – | – |
|
975
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$217M
| $225K | ﹤0.01% |
5,541
| – | – |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.